Infectious Enteritis Treatment Market, By Treatment Type (Medications, Therapies, Vaccines, and Supportive Care), By Pathogen Type, By Route of Administration, By Distribution Channel, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Infectious Enteritis Treatment Market size was valued at US$ 490.54 Million in 2024, expanding at a CAGR of 7.20% from 2025 to 2032.
The Infectious Enteritis Treatment Market is centered around various medications, therapies, and medical interventions designed to address infectious enteritis, a condition that causes inflammation of the intestines due to pathogens such as bacteria, viruses, or parasites. This condition manifests with symptoms like diarrhea, abdominal pain, nausea, and vomiting, with common culprits including rotavirus, norovirus, E. coli, and Salmonella. Treatment options vary depending on the specific infection and its severity and may include oral rehydration therapy (ORT), antibiotics, antivirals, and probiotics to restore intestinal balance. Key treatment providers include hospitals, clinics, and pharmacies. The increasing prevalence of foodborne diseases, along with water contamination, has significantly boosted the demand for these treatments. Moreover, innovations in rapid diagnostic tools enhance early detection and enable prompt intervention. Government initiatives, such as vaccination programs for rotavirus, also contribute to market growth. Regions with poor sanitation infrastructure are particularly affected, driving demand for affordable and accessible treatment options. With ongoing research by pharmaceutical companies to develop advanced therapies, including combination drugs and treatments for resistant pathogens, the market continues to expand in response to rising healthcare needs and technological progress.
Infectious Enteritis Treatment Market- Market Dynamics
Ø Rising prevalence of foodborne illnesses increasing treatment demand globally.
The rising prevalence of foodborne illnesses is a major factor driving the infectious enteritis treatment market. Contaminated food and water are primary sources of bacterial, viral, and parasitic infections, leading to conditions like diarrhea and gastroenteritis. According to the World Health Organization (WHO), millions of people are affected by foodborne diseases annually, heightening the demand for treatments such as antibiotics, oral rehydration solutions (ORS), and probiotics. Contributing factors include rapid urbanization, poor sanitation, and improper food handling, particularly in developing regions. Additionally, increased global travel and trade have facilitated the spread of foodborne pathogens. The growing issue of antibiotic-resistant bacteria has spurred research into advanced therapies and combination treatments. Public health campaigns have helped improve early diagnosis, further boosting market growth. Government investments in vaccination programs, such as rotavirus immunization, have also reduced severe viral enteritis cases, supporting the overall expansion of the market.
Infectious Enteritis Treatment Market- Segmentation Analysis:
The Global Infectious Enteritis Treatment Market is segmented on the basis of Treatment Type, Pathogen Type, Route of Administration, Distribution Channel, End User, and Region.
The market is divided into four categories based on Treatment Type: Medications, Therapies, Vaccines, Supportive Care. Medications are the dominant segment in the infectious enteritis treatment market, essential for managing bacterial, viral, and parasitic infections. Antibiotics are used for bacterial enteritis, while antivirals and antiparasitic drugs target viral and parasitic causes. The growing issue of antibiotic resistance has increased the demand for combination therapies and next-generation antibiotics. Oral rehydration solutions (ORS) are vital for treating dehydration, while the rise of online pharmacies and telemedicine has improved access to these critical treatments.
The market is divided into three categories based on Pathogen Type: Bacterial, Viral, Parasitic. The bacterial segment leads the infectious enteritis treatment market, driven by the high prevalence of foodborne illnesses caused by pathogens like Salmonella, E. coli, and Shigella. Bacterial enteritis is a major cause of hospitalizations, fueling demand for antibiotics and supportive therapies. The rise of antibiotic-resistant strains has spurred research into advanced treatments. Contaminated food and water, particularly in developing regions, remain primary transmission sources, while rapid diagnostic advancements enable quicker interventions, supporting the segment\'s dominance..
Infectious Enteritis Treatment Market- Geographical Insights
North America holds a significant share of the infectious enteritis treatment market, primarily driven by high healthcare spending and advanced medical infrastructure. The United States leads the region, with a rising prevalence of foodborne illnesses, as reported by the Centers for Disease Control and Prevention (CDC), which estimates 48 million foodborne illness cases annually. Increased awareness of hygiene, sanitation, and strong vaccination programs, such as rotavirus immunization for infants, contribute to market growth. Canada is also experiencing a rise in enteritis cases, driven by contaminated food and water sources, resulting in greater demand for rapid diagnostic tools and effective treatments. Ongoing research into new antibiotics and probiotics to combat antibiotic-resistant pathogens is further fueling the market. Additionally, favorable reimbursement policies and government initiatives supporting public health awareness are boosting market expansion. The rise of telemedicine and online pharmacies has also improved treatment accessibility across the region, reinforcing North America\'s market dominance.
Infectious Enteritis Treatment Market- Competitive Landscape:
The infectious enteritis treatment market is highly competitive, with major global pharmaceutical companies leading in drug development, vaccines, and supportive therapies. Prominent players like GlaxoSmithKline, Sanofi, and Merck are key in rotavirus vaccine production, vital for preventing viral enteritis. Pfizer, Johnson & Johnson, and Bayer dominate the antibiotic segment, addressing bacterial infections like Salmonella and E. coli. Companies such as Novartis and AbbVie are advancing research into probiotic therapies to restore gut health post-infection. With antibiotic resistance rising, there is increased focus on developing combination drugs. Partnerships, mergers, and acquisitions are common as companies expand portfolios and distribution networks. Additionally, investments in rapid diagnostic tools are on the rise, with Roche and Gilead Sciences integrating advanced technologies for early detection. Emerging players are focusing on cost-effective treatments to meet demand in developing regions. Overall, strong R&D pipelines, technological advancements, and strategic collaborations are driving the market’s competitive landscape.
Recent Developments:
v In November 2022, GSK plc received FDA approval for a new oral-dosing applicator-only version of ROTARIX, its rotavirus vaccine. This innovation eliminates the need for dose reconstitution, offering greater convenience for healthcare providers and strengthening GSK\'s business portfolio.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø GlaxoSmithKline plc
Ø Sanofi S.A.
Ø Johnson & Johnson
Ø Merck & Co., Inc.
Ø Pfizer Inc.
Ø Bayer AG
Ø Novartis AG
Ø AbbVie Inc.
Ø Eli Lilly and Company
Ø F. Hoffmann-La Roche Ltd
Ø Takeda Pharmaceutical Company Limited
Ø AstraZeneca plc
Ø Bristol-Myers Squibb Company
Ø Boehringer Ingelheim International GmbH
Ø Cipla Limited
Ø Gilead Sciences, Inc.
Ø Sun Pharmaceutical Industries Ltd
GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Medications
Ø Therapies
Ø Vaccines
Ø Supportive Care
GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Bacterial
Ø Viral
Ø Parasitic
GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
Ø Oral
Ø Intravenous (IV)
Ø Injectable
GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
Ø Hospital Pharmacies
Ø Retail Pharmacies
Ø Online Pharmacies
GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Ø Hospitals
Ø Clinics
Ø Ambulatory Surgical Centers (ASCs)
Ø Retail Pharmacies
Ø Online Pharmacies
GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o U.S.
o Canada
Ø Europe
o Germany
o UK
o France
o Italy
o Spain
o The Netherlands
o Sweden
o Russia
o Poland
o Rest of Europe
Ø Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o Indonesia
o Thailand
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Infectious Enteritis Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Infectious Enteritis Treatment Market Snippet by Treatment Type
2.1.2. Infectious Enteritis Treatment Market Snippet by Pathogen Type
2.1.3. Infectious Enteritis Treatment Market Snippet by Route of Administration
2.1.4. Infectious Enteritis Treatment Market Snippet by Distribution Channel
2.1.5. Infectious Enteritis Treatment Market Snippet by End User
2.1.6. Infectious Enteritis Treatment Market Snippet by Country
2.1.7. Infectious Enteritis Treatment Market Snippet by Region
2.2. Competitive Insights
3. Infectious Enteritis Treatment Key Market Trends
3.1. Infectious Enteritis Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Infectious Enteritis Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Infectious Enteritis Treatment Market Opportunities
3.4. Infectious Enteritis Treatment Market Future Trends
4. Infectious Enteritis Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Infectious Enteritis Treatment Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Infectious Enteritis Treatment Market Landscape
6.1. Infectious Enteritis Treatment Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Infectious Enteritis Treatment Market – By Treatment Type
7.1. Overview
7.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
7.1.2. Medications
7.1.3. Therapies
7.1.4. Vaccines
7.1.5. Supportive Care
8. Infectious Enteritis Treatment Market – By Pathogen Type
8.1. Overview
8.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
8.1.2. Bacterial
8.1.3. Viral
8.1.4. Parasitic
9. Infectious Enteritis Treatment Market – By Route of Administration
9.1. Overview
9.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
9.1.2. Oral
9.1.3. Intravenous (IV)
9.1.4. Injectable
10. Infectious Enteritis Treatment Market – By Distribution Channel
10.1. Overview
10.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
10.1.2. Hospital Pharmacies
10.1.3. Retail Pharmacies
10.1.4. Online Pharmacies
11. Infectious Enteritis Treatment Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Hospitals
11.1.3. Clinics
11.1.4. Ambulatory Surgical Centers (ASCs)
11.1.5. Retail Pharmacies
11.1.6. Online Pharmacies
12. Infectious Enteritis Treatment Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Infectious Enteritis Treatment Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Infectious Enteritis Treatment Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Infectious Enteritis Treatment Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Infectious Enteritis Treatment Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Infectious Enteritis Treatment Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Infectious Enteritis Treatment Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. GlaxoSmithKline plc
13.2.2. Sanofi S.A.
13.2.3. Johnson & Johnson
13.2.4. Merck & Co., Inc.
13.2.5. Pfizer Inc.
13.2.6. Bayer AG
13.2.7. Novartis AG
13.2.8. AbbVie Inc.
13.2.9. Eli Lilly and Company
13.2.10. F. Hoffmann-La Roche Ltd
13.2.11. Takeda Pharmaceutical Company Limited
13.2.12. AstraZeneca plc
13.2.13. Bristol-Myers Squibb Company
13.2.14. Boehringer Ingelheim International GmbH
13.2.15. Cipla Limited
13.2.16. Gilead Sciences, Inc.
13.2.17. Sun Pharmaceutical Industries Ltd
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
